alert icon Coronavirus
Now scheduling COVID-19 vaccines for ages 5+, boosters and third doses
Schedule your appointment
COVID-19 vaccine FAQs

Going to a Cleveland Clinic location?
New visitation guidelines
Masks required for patients and visitors (even if you're vaccinated)

Department Transplantation Center
Primary Location Cleveland Clinic Main Campus
Type of Doctor Both Adults and Children & Adolescents
Languages Arabic, English
Surgeon Yes
Locations Specialties & Treatments

Treatment & Services

  • Cancer Center
  • Distal Splenorenal Shunt
  • Intestinal Rehabilitation & Transplant
  • Intestinal Transplant
  • Pediatric Liver Transplantation
  • Small Bowel Transplant
  • Transplantation
View all 7 Treatment & Services +

Specialty in Diseases & Conditions

  • Autoimmune Chronic Hepatitis
  • Portal Hypertension
  • Primary Biliary Cirrhosis
  • Primary Sclerosing Cholangitis
View all 4 Specialties +


Is Cleveland Clinic Part of Your Insurance?

Review a list of accepted insurance plans for our Northeast Ohio locations or learn more about purchasing a contracted managed care plan.

View All Plans

About Kareem Abu-Elmagd, MD, PhD

Kareem Abu-Elmagd, MD, PhD,has joined the Department of General Surgery in the Digestive Disease and Surgery Institute as Director of the Intestinal Transplant Program. During the next few months, Dr. Abu-Elmagd will take on leadership of the Transplant Center from John Fung, MD, Chairman of the Digestive Disease and Surgery Institute, who has directed the center until now. Dr. Abu-Elmagd has led the Intestinal Rehabilitation and Transplant Center at the University of Pittsburgh (UPMC) since its establishment in 1999 and has earned an international reputation for clinical and technical contributions to the field of transplantation. He has authored more than 300 original publications and 40 book chapters. He is an active member of 13 prominent professional and scientific societies.

In 1999, Dr. Abu-Elmagd convinced the Center for Medicare and Medicaid Services (CMS) that, due to improved survival rates, intestinal and multivisceral transplantation programs should receive reimbursement.

In addition to his clinical and surgical expertise in the field of liver transplantation, Dr. Abu-Elmagd has also made significant global contributions to the field of portal hypertensive surgery. He played a pivotal role in the development and introduction of the immunosuppressive drug FK506, also known as Prograf.

Education & Professional Highlights

Education & Professional Highlights


Education & Fellowships

Residency - University of Pittsburgh Medical Center
General Surgery
Pittsburgh, PA USA

Fellowship - University of Pittsburgh Medical Center
Pittsburgh, PA USA

Medical Education - Mansoura University School of Medicine

Medical Education - Emory University School of Medicine
Atlanta, GA USA

Medical Education - Emory University School of Medicine
Atlanta, GA USA

Medical Education - Wayne State University
Detroit, MI USA

Residency - Mansoura University Hospital
Surgical Resident

Graduate School - Mansoura University School of Medicine

Residency - Hurghada General Hospital
Surgical Resident

Medical Education - Mansoura University School of Medicine

Professional Highlights

  • President, Intestinal Transplant Association


  • Surgery - General Surgery


  • American Association for the Study of Liver Diseases
  • The International Liver Transplantation Society
  • The American Medical Association
  • The American Society of Transplant Surgeons
  • The American Society of Transplantation
  • The Transplantation Society
  • The American Surgical Society
  • The American Surgical Association
Research & Publications

Research & Publications

See publications for Kareem Abu-Elmagd, MD, PhD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Industry Relationships

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 1/12/2021, Dr. Abu-Elmagd has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Patient Satisfaction Reviews

36 Patient Satisfaction Reviews

The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

The comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Cleveland Clinic.

Overall Star Ratings
4.6 out of 5
Explains 4.6
Listens 4.4
Courtesy, Respect & Concern 4.7
Patient Rating of Doctor 4.7

12 Patient Comments

Reviewed on Oct 25, 2021

Excellent Doctor Excellent Colleagues Excellent Staff

Reviewed on Sep 15, 2021

The nurse, doctor were outstanding and very supportive and provided very clear instructions and follow up.

Reviewed on Aug 18, 2021

I trust Dr. Kareem Abu-Elmagd with my life.

Reviewed on Aug 9, 2021

Dr. Kareem if outstanding!!

Reviewed on May 3, 2021

Dr Kareem always does an amazing job listening and supporting my decisions regarding my medical care.

Reviewed on Apr 5, 2021

Dr Kareem is a n amazing doctor and a n absolute gem!!!

Reviewed on Mar 24, 2021

Dr. Kareem understands what is going on with my small intestine and knows this is a real concern for my health and that it is putting a lot of stress on me mentally besides the physical problems as well.

Reviewed on Feb 15, 2021

I would not seek care with Dr. Kareem. I believe he did not study my case and had no interest in me. I felt like he was going through the motions for a co pay. total waste of my time and effort. I would not recommend.

Reviewed on Feb 15, 2021

I would not come back. I was seen by two providers and no follow thru or interest.

Reviewed on Feb 8, 2021

Very well done, Dr. Kareem was able to show me mt CT scan and go through it step by step.

Reviewed on Feb 8, 2021

We need more Doctors like Dr. Kareem! The best Doctor ever.

Reviewed on Jan 25, 2021

Dr. Kareem and his team have been nothing but amazing from the very beginning. No matter how far away you are from Cleveland Clinic, him and his team provide the best care I've ever had! he truly puts his patients first and cares for them like family. He listens greatly and is very determined to figure out the problem and fix it!

Related Videos Featuring Kareem Abu-Elmagd, MD, PhD

Related Videos Featuring Kareem Abu-Elmagd, MD, PhD

Back to Top